Loading...
An alternative pathway for membrane protein biogenesis at the endoplasmic reticulum.
O'Keefe, Sarah; orcid: 0000-0002-1744-0198; email: sarah.okeefe@manchester.ac.uk ; Zong, Guanghui; orcid: 0000-0002-7335-039X ; Duah, Kwabena B ; Andrews, Lauren E ; Shi, Wei Q; orcid: 0000-0001-5453-1753 ; High, Stephen; orcid: 0000-0002-4532-8152; email: stephen.high@manchester.ac.uk
O'Keefe, Sarah; orcid: 0000-0002-1744-0198; email: sarah.okeefe@manchester.ac.uk
Zong, Guanghui; orcid: 0000-0002-7335-039X
Duah, Kwabena B
Andrews, Lauren E
Shi, Wei Q; orcid: 0000-0001-5453-1753
High, Stephen; orcid: 0000-0002-4532-8152; email: stephen.high@manchester.ac.uk
Advisors
Editors
Other Contributors
Affiliation
EPub Date
Publication Date
2021-07-01
Submitted Date
Collections
Files
Loading...
article.pdf
Adobe PDF, 1.97 MB
Other Titles
Abstract
The heterotrimeric Sec61 complex is a major site for the biogenesis of transmembrane proteins (TMPs), accepting nascent TMP precursors that are targeted to the endoplasmic reticulum (ER) by the signal recognition particle (SRP). Unlike most single-spanning membrane proteins, the integration of type III TMPs is completely resistant to small molecule inhibitors of the Sec61 translocon. Using siRNA-mediated depletion of specific ER components, in combination with the potent Sec61 inhibitor ipomoeassin F (Ipom-F), we show that type III TMPs utilise a distinct pathway for membrane integration at the ER. Hence, following SRP-mediated delivery to the ER, type III TMPs can uniquely access the membrane insertase activity of the ER membrane complex (EMC) via a mechanism that is facilitated by the Sec61 translocon. This alternative EMC-mediated insertion pathway allows type III TMPs to bypass the Ipom-F-mediated blockade of membrane integration that is seen with obligate Sec61 clients.
Citation
Communications biology, volume 4, issue 1, page 828
Publisher
Journal
Research Unit
DOI
PubMed ID
PubMed Central ID
Type
article
Language
Description
From Europe PMC via Jisc Publications Router
History: epub 2021-07-01, ppub 2021-07-01
Publication status: Published
Funder: Ball State University (Ball State); Grant(s): Provost Startup Award
Funder: Wellcome Trust; Grant(s): 204957/Z/16/Z
Funder: NIGMS NIH HHS; Grant(s): R15 GM116032
History: epub 2021-07-01, ppub 2021-07-01
Publication status: Published
Funder: Ball State University (Ball State); Grant(s): Provost Startup Award
Funder: Wellcome Trust; Grant(s): 204957/Z/16/Z
Funder: NIGMS NIH HHS; Grant(s): R15 GM116032
